NUVB NUVATION BIO CLASS A
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 14 analyst firms say about NUVATION BIO CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 15 analyst/firm records · 14 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 8 reports on NUVB from 7 analyst firms in the last 90 days (14 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: RBC Capital lowered its target from $20.00 (set 7 Aug 2026) to $17.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 29 Jun 2026 | 14.00 USD |
| Cantor Fitzgerald | Li Watsek | Buy | 21 Aug 2026 | — |
| Citigroup | Geoff Meacham | Buy | 19 Oct 2026 | 12.00 USD · 30 Sep 2026 |
| Citizens JMP | Silvan C Tuerkcan | Buy | 16 Sep 2026 | 10.00 USD |
| Citizens JMP | Silvan Turkcan | Buy | 16 Sep 2026 | 10.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 27 Jul 2026 | 21.00 USD |
| Jonestrading | Soumit Roy | Buy | 5 May 2026 | 12.00 USD |
| JPMorgan | Priyanka Grover | Buy | 18 Aug 2026 | 13.00 USD |
| RBC Capital Markets | Leonid Timashev | Buy | 7 Aug 2026 | 20.00 USD |
| TD Cowen | Yaron Werber | Buy | 15 Jun 2026 | — |
| Truist | Gregory Renza | Buy | 7 Jul 2026 | 13.00 USD |
| UBS | Michael J Yee | Hold | 7 Aug 2026 | 7.00 USD |
| Wedbush | David Nierengarten | Buy | 16 Sep 2026 | 11.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 6 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.